Azenta, Inc.
William E. Martin III (President Multiomics) reports AZTA insider transactions
About this filing
Azenta, Inc. (AZTA) filed Form 4 (insider transaction) with the SEC on Sep 16, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- William E. Martin III · President Multiomics
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | A · grantFootnotes F1 | +15,272 | $0.00 | $0.00 | 33,062 | Direct |
Footnotes
- F1 Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement.
More AZTA filings
- 8-K
Filed Oct 30, 2026
- 4
Filed Oct 23, 2026
- 8-K
Filed Oct 7, 2026
- 4
Filed Sep 23, 2026
- 8-K
Filed Sep 17, 2026
- 4
Filed Sep 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.